Search
for
Sort by
Research 61–90 of 1000+
- The human skin as a hormone target and an endocrine gland
- The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results
- Biochemical and trichological characterization of diffuse alopecia in women
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- The rationale for physiological testosterone replacement in women
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Congenital adrenal hyperplasia
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Hair: A Review of Prominent Scalp Hair Changes throughout a Females’ Life
- Ovarian Hypertension: Polycystic Ovary Syndrome
- 9 Role of 5α-reductase in health and disease
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- HAIR AND SYSTEMATIC DISEASE
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Diagnosis: Alopecia areata or not?
- Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells
- Frontal fibrosing alopecia in postmenopausal women
- Adult polycystic ovary syndrome begins in childhood
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Novel adenosine triphosphate (ATP)-binding cassette, subfamily A, member 12 (ABCA12) mutations associated with congenital ichthyosiform erythroderma
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Androgens and hair: a biological paradox
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases